Replacement: Director/PDMR Shareholding

RNS Number : 4813U
Judges Scientific PLC
16 October 2014
 

MULTIPLE NON-MATERIAL TEXT AMENDMENTS

 

A number of non-material typographical changes have been made to the 'Director/PDMR Shareholding' announcement released on 08/10/14 at 14.31 under RNS No 7995T. The changes are identified with an asterisk (*).

 

11* Ordinary shares were acquired by David Cicurel, his resulting interest in the Company is 916,497*.

 

11* Ordinary shares were acquired by Ralph Cohen, his resulting interest in the Company is 58,016*.

 

A further 565* Ordinary Shares were made on the same date and at the same price on behalf of 61 other members of staff under the Plan

 

All other details remain unchanged. The full amended text is shown below.

 

 

Judges Scientific plc (the "Company")

 

16 October 2014

 

 

Director/PDMR Shareholding

 

Judges Scientific has been advised that purchases of Ordinary Shares of 5p each in the Company ("Ordinary Shares") were made on 6 October 2014 by the Trustees of the Share Incentive Plan on behalf of two Directors of the Company, as follows:

 

A total of 11 Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company.  His resulting interest in the Company is 916,497 Ordinary Shares representing 15.28 per cent of the issued Ordinary share capital.  In addition, he holds options over 1,775 Ordinary Shares under the Company's Share Option Plans.

 

A total of 11 Ordinary Shares were purchased on behalf of Ralph Cohen, the Finance Director of the Company.  His resulting interest in the Company is 58,016 Ordinary Shares representing 0.97 per cent of the issued Ordinary share capital.  In addition, he holds options over 7,875 Ordinary Shares under the Company's Share Option Plans.

 

The purchases by the Trustees were made at a price of 1335.00p per Ordinary Share.  Purchases of a further 565 Ordinary Shares were made on the same date and at the same price on behalf of 61 other members of staff under the Plan.

 

 

For further information please contact:

Judges Scientific plc

David Cicurel, CEO

Tel: 01342 323 600

 

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

 

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 020 7930 0777 or 07775 896 491

 

 

Website:

Judges Scientific: www.judges.uk.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAPEKFDPLFEF
UK 100

Latest directors dealings